Predicting heart failure symptoms by plasma N-terminal pro B-type natriuretic peptide for patients with chronic aortic regurgitation and preserved left ventricular function

Acta Cardiologica Sinica

Volumn 24, Issue 1, 2008, Pages 29-34

  Chou, Po Ching ^a   Chin, Chih Hui ^a   Lin, Ching Ling ^a   Chen, Chung Huo ^a   Chen, Thay Hsiung ^a   Chiou, Herng Cheng ^a  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

Aortic regurgitation; Congestive heart failure; N terminal proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; AORTA VALVE REGURGITATION; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE OVERLOAD; HEART VOLUME; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SYMPTOM;

EID: 44849112574     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hosoda K, NaKao K, Mukoyama M, Saito Y, Jougasaki M, Shirakami G, et al. Expression of brain natriuretic peptide gene in human heart: production in the ventricle. Hypertension 1991;17:1152-5.
2. Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, et al. Rapid ventricular activation of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 1995;92:1558-64.
3. Omland T, Aakvaag A, Bonarjee V, Caidahl K, Lie R, Nilsen D, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Circulation 1996;93:1963-9.
4. Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K, Akioka K, et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1992;92:29-34.
5. Wieczorek SJ, Wu A, Christenson R, Krishnaswamy P, Gottlieb S, Rosano T, et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J 2002;144:834-9.
6. Valli N, Gobinet A, Bordenave L. Review of 10 years of the clinical use of brain natriuretic peptide in cardiology. J Lab Clin Med 1999;134:437-44.
7. Hunt PJ, Richards AM, Nicholls MG, Yandlw TG, Doughty RN, Espiner EA. Immunoreactive aminoterminal pro-brain natriuretic peptide (NT-proBNP): a new marker for cardiac impairment. Clin Endocrinol 1997;47:287-96.
8. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, et al. Biochemical detection of left ventricular systolic dysfunction. Lancet 1998;351:9-13.
9. De Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. New Eng J Med 2001;345:1014-21.
10. Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR, Seward JB, Tajik AJ. Mortality and morbidity of aortic regurgitation in clinical practice: a long-term follow-up study. Circulation 1999;99:1851-7.
11. Goldschlager N, Pfeifer J, Cohn K, Popper R, Selzer A. The natural history of aortic regurgitation: a clinical and hemodynamic study. Am J Med 1973;54:577-88.
12. Bonow RO, Lakatos E, Maron BJ, Epstein SE. Serial long-term assessment of the natural history of asymptomatic patients with chronic regurgitation and normal left ventricular systolic function. Circulation 1991;84:1625-35.
13. Chin CH, Chen CH, Chen CC, Chang ML, Chen TH, Chiou HC. Value of parasternal long-axis vena contracta width for predicting severity of aortic regurgitation in left ventricular systolic dysfunction. Am J Cardiol 2003;92:1355-8.
14. Chin CH, Chen CH, Chen CC, Chang ML, Chen TH, Chiou HC. Prediction of severity of isolated aortic regurgitation by echocardiography: an aortic regurgitation index study. J Am Soc Echocardiogr 2005;18:1007-13.
15. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802.
16. Enriquez-Sarano M, Bailey KR, Seward JB, Tajik AJ, Krohn MJ, Mays JM. Quantitative Doppler assessment of valvular regurgitation. Circulation 1993;87:841-8.
17. Enriquez-Sarano M, Seward JB, Bailey KR, Tajik AJ. Effective regurgitant orifice area: a noninvasive Doppler development of an old hemodynamic concept. J Am Coll Cardiol 1994;23:443-5.
18. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8.
19. American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart disease). ACC/AHA guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 1998;32:1486-588.
20. Weber M, Arnold R, Rau M, Elsaesser A, Brandt R, Mitrovic V, Hamm C. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J 2005;26:1023-30.
21. Eimer MJ, Ekery DL, Rigolin VH, Bonow RO, Carnethon MR, Cotts WG. Elevated B-type natriuretic peptide in asymptomatic men with chronic aortic regurgitation and preserved left ventricular systolic function. Am J Cardiol 2004;94:676-8.
22. Gerber IL, Stewart RAH, French JK, Legget ME, Greaves SC, West TM, et al. Associations between plasma natriuretic peptide levels, symptoms, and left ventricular function in patients with chronic aortic regurgitation. Am J Cardiol 2003;92:755-8.
23. Turina J, Milincic J, Seifert B, Turina M. Valve replacement in chronic aortic regurgitation: true predictors of survival after extended follow-up. Circulation 1998;98:100-6.